Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S, M.D (Internal Medicine)
Consultant Physician
M.B.B.S, MCPS
General Physician
M.B.B.S., M.C.P.S
Diabetologist
M.B.B.S, M.Phil.
Consultant Physician
M.B.B.S., M.C.P.S
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Diabetologist
M.B.B.S, M.C.P.S, Certification in Family Medicine, Master Trainer Family Medicine, MRCGP International UK
Diabetologist
M.B.B.S, M.C.P.S, Certification in Family Medicine, Master Trainer Family Medicine, MRCGP International UK
Diabetologist
MBBS, FRCP (Ed.), FRCP (Glasg.), MRCP (UK), FACP (USA), FACC (USA), FASIM (USA), M.D
Diabetologist
MBBS, FRCP (Ed.), FRCP (Glasg.), MRCP (UK), FACP (USA), FACC (USA), FASIM (USA), M.D
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures